Hakusana (engl): Kutaaninen Systeeminen Skleroosi ja MMP- järjestelmä

 Katsottava myöhemmin: ja suomennettava yhteenveto. Lehdessä mainittiin kutaaninen systeeminen skleroosi parantumattomaksi taudiksi tänään gp:ssä.

Results: 14

Select item 223842001.

A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.

Noda S, Asano Y, Akamata K, Aozasa N, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S.

PLoS One. 2012;7(2):e32272. doi: 10.1371/journal.pone.0032272. Epub 2012 Feb 23.

PMID:

22384200

[PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 223670962.

Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.

Brown M, Postlethwaite AE, Myers LK, Hasty KA.

Clin Rheumatol. 2012 Jun;31(6):973-81. doi: 10.1007/s10067-012-1962-z. Epub 2012 Feb 25.

PMID:

22367096

[PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 222584863.

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.

Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2012 Jun;71(6):1064-72. doi: 10.1136/annrheumdis-2011-200837. Epub 2012 Jan 17.

PMID:

22258486

[PubMed - indexed for MEDLINE]

Related citations

Select item 205952764.

Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population.

Manetti M, Ibba-Manneschi L, Fatini C, Guiducci S, Cuomo G, Bonino C, Bazzichi L, Liakouli V, Giacomelli R, Abbate R, Bombardieri S, Montecucco C, Valentini G, Matucci-Cerinic M.

J Rheumatol. 2010 Sep;37(9):1852-7. doi: 10.3899/jrheum.100237. Epub 2010 Jul 1.

PMID:

20595276

[PubMed - indexed for MEDLINE]

Related citations

Select item 187043175.

Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications.

Meng C, Chen X, Li J, Wu Y, Liu H.

J Huazhong Univ Sci Technolog Med Sci. 2008 Aug;28(4):480-2. doi: 10.1007/s11596-008-0424-y. Epub 2008 Aug 15.

PMID:

18704317

[PubMed - indexed for MEDLINE]

Related citations

Select item 185657356.

Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.

Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.

J Dermatol Sci. 2008 Oct;52(1):47-54. doi: 10.1016/j.jdermsci.2008.04.013. Epub 2008 Jun 18.

PMID:

18565735

[PubMed - indexed for MEDLINE]

Related citations

Select item 162782857.

Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.

Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K.

Rheumatology (Oxford). 2006 Mar;45(3):303-7. Epub 2005 Nov 8.

PMID:

16278285

[PubMed - indexed for MEDLINE]

Free Article

Related citations

Select item 154980498.

Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.

Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, Sato S.

Clin Exp Immunol. 2004 Nov;138(2):357-63.

PMID:

15498049

[PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 126482159.

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K.

J Invest Dermatol. 2003 Apr;120(4):542-7.

PMID:

12648215

[PubMed - indexed for MEDLINE]

Free Article

Related citations

Select item 1259411810.

Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline.

Robertson LP, Marshall RW, Hickling P.

Ann Rheum Dis. 2003 Mar;62(3):267-9.

PMID:

12594118

[PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 1213967611.

Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.

Kikuchi K, Kubo M, Hoashi T, Tamaki K.

Clin Exp Dermatol. 2002 Jun;27(4):301-5.

PMID:

12139676

[PubMed - indexed for MEDLINE]

Related citations

Select item 1150261112.

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.

Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.

Ann Rheum Dis. 2001 Sep;60(9):846-51.

PMID:

11502611

[PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 1060732213.

Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis.

Yazawa N, Kikuchi K, Ihn H, Fujimoto M, Kubo M, Tamaki T, Tamaki K.

J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):70-5.

PMID:

10607322

[PubMed - indexed for MEDLINE]

Related citations

Select item 954098514.

Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts.

Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U, Kähäri VM.

J Invest Dermatol. 1998 Apr;110(4):416-21.

PMID:

9540985

[PubMed - indexed for MEDLINE]

Free Article

Related citations